false
OasisLMS
Login
Catalog
Expanding the Orthopedic DME Portfolio: Beyond Tra ...
Slides
Slides
Back to course
Pdf Summary
The presentation outlines a value-based approach to expanding an orthopedic durable medical equipment (DME) portfolio. New programs should address patient needs, support clinical pathways, and be financially and operationally sustainable.<br /><br />Potential opportunities span biologics and injectables, cold therapy and postoperative recovery, bone growth stimulation, and advanced or specialty bracing. Organizations can introduce new offerings, expand established programs, or improve utilization.<br /><br />Before investing, DME leaders should assess four factors: clinical value, physician adoption, financial viability, and operational readiness. Based on this evaluation, an opportunity may be launched, piloted, refined, or deferred.<br /><br />Successful implementation depends on physician engagement: identify a clinical champion, align the team on evidence and product selection, standardize protocols and workflows, and use feedback and utilization data to refine the program. Scaling also requires coordinated patient identification, ordering, delivery, follow-up, staff training, inventory management, reimbursement, and compliance, with clear ownership and accountability.<br /><br />Examples include expanding cold therapy from sports medicine to total joint care, adding osteoarthritis knee bracing to strengthen conservative care, and piloting platelet-rich plasma (PRP) after validating its clinical capabilities, costs, workflow, and demand. The central message is to expand thoughtfully—matching patient and clinical needs with reliable operations and a viable payment model.
Keywords
orthopedic DME
value-based care
biologics
cold therapy
postoperative recovery
bone growth stimulation
specialty bracing
physician engagement
reimbursement
clinical pathways
×
Please select your language
1
English